Cargando…
Vaccine Vigilance System: Considerations on the Effectiveness of Vigilance Data Use in COVID-19 Vaccination
(1) Background: The safety of medicines has been receiving increased attention to ensure that the risks of taking medicines do not outweigh the benefits. This is the reason why, over several decades, the pharmacovigilance system has been developed. The post-authorization pharmacovigilance system is...
Autores principales: | Araja, Diana, Krumina, Angelika, Nora-Krukle, Zaiga, Berkis, Uldis, Murovska, Modra |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9783025/ https://www.ncbi.nlm.nih.gov/pubmed/36560525 http://dx.doi.org/10.3390/vaccines10122115 |
Ejemplares similares
-
Coaching to strengthen critical success factors in integrative care for chronic fatigue patients: the Patient Needs-Resources Model
por: Araja, Diana, et al.
Publicado: (2023) -
COVID-19 Pandemic-Revealed Consistencies and Inconsistencies in Healthcare: A Medical and Organizational View
por: Araja, Diana, et al.
Publicado: (2022) -
Shadow Burden of Undiagnosed Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS) on Society: Retrospective and Prospective—In Light of COVID-19
por: Araja, Diana, et al.
Publicado: (2021) -
Clinical Profile and Aspects of Differential Diagnosis in Patients with ME/CFS from Latvia
por: Krumina, Angelika, et al.
Publicado: (2021) -
Potential of Activin B as a Clinical Biomarker in Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS)
por: Gravelsina, Sabine, et al.
Publicado: (2021)